The Validation and Biological Index Studies on the Improved Social Function of ASD by 40 Hz tACS - Trial NCT06362200
Access comprehensive clinical trial information for NCT06362200 through Pure Global AI's free database. This phase not specified trial is sponsored by Central South University and is currently Not yet recruiting. The study focuses on Autism Spectrum Disorder. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Central South University
Timeline & Enrollment
N/A
Apr 15, 2024
Dec 31, 2028
Primary Outcome
Autism assessment assessment index
Summary
In this proposed study, tACS will be used to intervene in the autism spectrum disorders of
 children and adolescents, and the efficacy of this intervention method will be evaluated, as
 well as the internal mechanism of adolescents' autism spectrum disorders will be discussed.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06362200
Device Trial